LiveCare, Inc. (OTCPK: LVCE)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
LiveCare, Inc. (OTCPK: LVCE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $357.22K and employs 2 people.
trading between 0.00 and 0.10.
Tweenvest scores LiveCare, Inc. across four factors: quality 42/100, value 56/100. Its strongest factor is value.
LVCE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $357.22K
- Revenue (TTM)
- $3.60M
- P/E
- —
- EPS
- -0.24
- Dividend yield
- —
- Beta (5Y)
- 1.11
- 52-week high
- $0.10
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 61.59M
- Employees
- 2
- Next earnings
- —
About LiveCare, Inc.
LiveCare, Inc. is committed to tackling the pervasive diabetic epidemic and other chronic illnesses by blending cutting-edge technological advancements with a personalized, human-centric approach. Specializing in real-time health data analysis, support services, and patient monitoring, the company primarily delivers targeted solutions to individuals afflicted with Type II diabetes. This firm was established in 2018 and operates out of its headquarters in Venice, Florida.
- ISIN
- US53814W1045
- Founded
- 2018
- Listed since
- Sep 30, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| RAMM Pharma Corp.CNSX: RAMM | $419.20K | CA$0.01 | -50.00% |
| MPS Pharmaa LimitedBSE: 531686 | $412.76K | Rs2.08 | +4.52% |
| NeoRich BioPharma Tech Co., LimitedOTCPK: NRBP | $404.44K | $1.17 | +216.13% |
| CNBX Pharmaceuticals Inc.OTCPK: CNBX | $385.15K | $0.00 | +100.00% |
| Digicann Ventures Inc.CNSX: DCNN.X | $337.85K | CA$0.02 | +100.00% |
| Lyra Therapeutics, Inc.OTCPK: LYRA | $337.23K | $0.19 | +26.67% |
| INDVR Brands Inc.MUN: 3YX | $330.26K | €— | — |
| Altamira Therapeutics Ltd.OTCPK: CYTO.F | $314.92K | $0.06 | -37.74% |
Figures last refreshed Oct 11, 2026.